Every cancer patient’s disease is as unique as their DNA. Each person’s cancer harbors a distinct set of genomic aberrations that can block the effectiveness of some treatments,…
Leptomeningeal metastasis, also known as malignant meningitis and referred to as “Lepto” or “LMD” amongst oncologists, is a life-threatening complication of cancers which have spread to the…
Data from a small clinical trial of venetoclax in acute myeloid leukemia (AML) supported an FDA breakthrough therapy designation for use in combination with hypomethylating agents in treatment-…
Ruxolitinib is approved for myelofibrosis due to the occurrence of a high frequency of the JAK2 mutation. However, other mutations are also reported in this indication. The FDA has approved…
Thymic tumors, while rare, are classified as orphan diseases due to their infrequency. Despite their rarity, they are the predominant tumors found in the anterior mediastinal compartment among…
STAY INFORMED
Top
